Elsevier, Bioorganic and Medicinal Chemistry Letters, 18(20), p. 5552-5558
DOI: 10.1016/j.bmcl.2010.07.043
Full text: Download
We report the identification of a novel NR2B-selective NMDAR antagonist with an original scaffold, LSP10-0500. This compound was identified by a virtual high-throughput screening approach on the basis of a quantitative pharmacophore model of NR2B-specific NMDAR antagonists. A SAR study around LSP10-0500 is also described.